Mylan Insulin Glargine Study

Summary

The aim of this study is to demonstrate similar efficacy and safety between MYL-1501D products produced from two manufacturing processes (Process V and Process VI) in combination with insulin lispro in patients with type 1 diabetes mellitus (T1DM).

Timeline

Start

2017-11-29

Primary completion

2018-09-25

Completion

2019-01-10

Drugs

Indications